Core Viewpoint - China Metallurgical Group Corporation (China MCC) has experienced a decline in stock price and financial performance, with significant drops in revenue and net profit year-on-year, indicating potential challenges ahead for the company [1][2]. Financial Performance - As of September 30, 2025, China MCC reported a revenue of 335.09 billion yuan, a year-on-year decrease of 18.79% [2]. - The net profit attributable to shareholders was 3.97 billion yuan, down 41.88% compared to the previous year [2]. - Year-to-date, the stock price has increased by 1.11%, but it has seen a decline of 6.55% over the last five trading days and 11.59% over the last 20 days [1]. Stock Market Activity - On November 18, the stock price fell by 2.09%, trading at 3.28 yuan per share with a total transaction volume of 418 million yuan [1]. - The net outflow of main funds was 38.96 million yuan, with large orders showing a buy of 96.11 million yuan and a sell of 97.03 million yuan [1]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased to 282,500, a reduction of 9.46% [2]. - The company has distributed a total of 17.21 billion yuan in dividends since its A-share listing, with 4.37 billion yuan distributed in the last three years [3]. Shareholding Structure - The top circulating shareholder, China Securities Finance Corporation, holds 589 million shares, unchanged from the previous period [3]. - Hong Kong Central Clearing Limited, the sixth-largest shareholder, reduced its holdings by 22.3 million shares [3].

Group 1 - The new policy financial tools have been fully deployed, supporting private investment and REITs issuance [2] - As of October 29, 500 billion yuan of new policy financial tools have been allocated, with a portion supporting key private investment projects [2] - A total of 18 private investment projects have been recommended to the CSRC, with 14 projects already issued, raising nearly 30 billion yuan [2] Group 2 - The central bank aims to maintain reasonable price levels and ensure steady growth, employment, and expectations [3] - In October, new social financing amounted to 815 billion yuan, a year-on-year decrease of 597 billion yuan [3] - The central bank emphasizes the importance of promoting reasonable price recovery as a key consideration in monetary policy [3] Group 3 - The National Energy Administration has issued guidelines to promote the integrated development of renewable energy [4] - The guidelines aim to enhance the complementary development of various renewable energy sources and optimize energy structures [4] - There is a focus on improving the collaborative development of wind, solar, hydrogen, and storage technologies [4] Group 4 - Recommendations include sectors such as copper and cobalt resources, energy storage, dividends, and infrastructure in the western region [5] - Specific stock recommendations include China Railway (601390) for copper, China Metallurgical (601618) for nickel, and China Construction (601668) for low valuation and high dividends [5] - The report also highlights opportunities in AI and low-altitude economy sectors, recommending companies like Design Institute (603357) and Huazhong International (002949) [5]

Core Viewpoint - China Metallurgical Group Corporation (China MCC) experienced a nearly 3% decline in stock price, attributed to a decrease in new contract signing and ongoing pressures in the steel, construction, and real estate sectors [1] Group 1: Financial Performance - For the period from January to October 2025, China MCC reported new contract signing amounting to RMB 845.07 billion, representing an 11.8% decrease compared to the same period last year [1] - The new overseas contract signing amounted to RMB 71.16 billion, which is a 7.3% increase year-on-year [1] Group 2: Analyst Predictions - Everbright Securities has revised its profit forecasts for China MCC, lowering the expected net profit attributable to shareholders for 2025 and 2026 to RMB 4.79 billion and RMB 4.99 billion, respectively, reflecting reductions of 30% and 26% [1] - The firm has introduced a new net profit forecast of RMB 5.23 billion for 2027 [1] Group 3: Market Outlook - Despite the challenges faced in the domestic market, Everbright Securities maintains a positive outlook on China MCC's overseas and resource business development, reiterating a "buy" rating for both A-shares and H-shares [1]

Core Viewpoint - China Metallurgical Group Corporation (China MCC) shares fell nearly 3%, trading at HKD 2.27 with a transaction volume of HKD 37.68 million [2] Group 1 - The stock price of China MCC decreased by 2.99% [2] - The current trading price is HKD 2.27 [2] - The trading volume reached HKD 37.68 million [2]

Core Points - China Metallurgical Group Corporation (China MCC) experienced a nearly 3% decline in stock price, trading at HKD 2.27 with a transaction volume of HKD 37.68 million [1] - As of November 14, China MCC announced that its new contract value for January to October 2025 was RMB 845.07 billion, a decrease of 11.8% compared to the same period last year [1] - The company reported that its new overseas contract value reached RMB 71.16 billion, reflecting a growth of 7.3% year-on-year [1] - Everbright Securities has downgraded the company's net profit forecasts for 2025 and 2026 to RMB 4.79 billion and RMB 4.99 billion, representing reductions of 30% and 26% respectively [1] - The new net profit forecast for 2027 is set at RMB 5.23 billion [1] - Despite the challenges faced in the steel, construction, and real estate sectors, Everbright Securities remains optimistic about the company's overseas and resource business development, maintaining a "buy" rating for both A-shares and H-shares [1]

Investment Rating - The industry investment rating is "Overweight" indicating a positive outlook for the sector [2][28]. Core Insights - Fixed asset investment growth has further declined, with a cumulative year-on-year decrease of 1.7% for January to October 2025, a drop of 1.2 percentage points compared to the previous period [4][5]. - Traditional infrastructure investment growth has turned negative, with infrastructure investment (excluding electricity) showing a year-on-year decrease of 0.1% [5]. - Real estate investment remains low, with a year-on-year decline of 14.7% for January to October 2025, indicating a weak recovery trajectory [11]. Summary by Sections Fixed Asset Investment - The cumulative year-on-year growth rate for fixed asset investment is -1.7%, with manufacturing investment at +2.7% [4]. - Infrastructure investment (all-inclusive) shows a year-on-year increase of 1.5%, but infrastructure investment excluding electricity is down by 0.1% [5]. Infrastructure Investment - Transportation, water conservancy, and public utility investments are under pressure, with transportation and postal services showing a slight increase of 0.1% year-on-year, while water and environmental management investments are down by 4.1% [5]. - Regional investment varies, with the eastern region down by 5.4% and the northeastern region down by 11.7% [5]. Real Estate Investment - Real estate investment has decreased by 14.7% year-on-year, with construction starts down by 19.8% and completions down by 16.9% [11]. - The report anticipates a slow recovery in real estate investment due to challenges in supply and inventory replenishment [11]. Investment Recommendations - The report suggests that in 2026, industry investment will stabilize, with emerging sectors expected to benefit from national strategic implementations [18]. - Specific companies to watch include Sichuan Road and Bridge, China Chemical, and others in the new infrastructure and overseas markets [18].

Group 1: Company Announcements - 合富中国's stock price increased by 256.29% over 14 trading days, significantly outperforming the industry and Shanghai Composite Index, leading to a suspension for verification starting November 17 [1] - 工业富联's GB300 achieved mass production in Q3, with improved yield and testing efficiency, positively impacting Q4 gross margin [2] - 天孚通信's controlling shareholder plans to transfer 8.5 million shares, representing 1.09% of total equity, due to personal funding needs [4] - 璞泰来 plans to invest 7.6 billion yuan in a new integrated film coating project, aiming to meet growing demand in the battery and energy storage sectors [5] - 电投能源 intends to acquire 100% of Baiyin Hua Coal Power for 11.149 billion yuan, financing through share issuance and cash [6] - 中微公司 reported that a shareholder completed a reduction of 12.52 million shares, totaling 3.351 billion yuan [7] - 瑞德智能 plans to invest 10 million yuan in a leading company in the power plant robotics sector [8] - 盘古智能 aims to acquire control of a petrochemical company by purchasing 11.97% of its shares for 24.64 million yuan [9] - 泰达股份 signed a memorandum for a waste-to-energy project in Egypt [10] - 杭氧股份 is set to establish a venture capital fund focusing on low-temperature technology and nuclear fusion [11] Group 2: Financial Performance and Regulatory Approvals - 复星医药's subsidiary received FDA approval for a biosimilar drug, with applications pending in China and Europe [21] - 长春高新 received approval for a clinical trial of a new growth hormone drug, with no similar products currently available in China [20] - 海辰药业 obtained a drug registration certificate for a new injection product [22] - 上海机场 reported a 12.46% year-on-year increase in passenger throughput for October [23] Group 3: Shareholder Actions - 深桑达 A plans to publicly transfer 80% of a subsidiary's shares with a minimum price of 1.857 billion yuan [12] - 中电港's major shareholder reduced its stake by 1% between October 31 and November 13 [15] - 康龙化成's major shareholders plan to collectively reduce their holdings by up to 1.5% [16] - 科兴制药's controlling shareholder intends to transfer 5% of its shares [17]

Core Insights - China Metallurgical Group Corporation (China MCC) reported a new contract signing amount of RMB 845.07 billion for the period from January to October 2025, representing a decrease of 11.8% compared to the same period last year [1] - The overseas contract signing amount reached RMB 71.16 billion, showing an increase of 7.3% year-on-year [1] Summary by Category Contract Performance - New contracts signed by China MCC from January to October 2025 totaled RMB 845.07 billion, down 11.8% from the previous year [1] - The company secured overseas contracts worth RMB 71.16 billion, which is an increase of 7.3% compared to the same period last year [1]

Group 1: China Construction - The total new contracts signed by China Construction from January to October reached 3.61 trillion yuan, representing a year-on-year increase of 1% [1] Group 2: Changyuan Power - Changyuan Power's subsidiary received approval for the 100MW wind power project in Songzi, Hubei [2] Group 3: China Metallurgical Group - China Metallurgical Group reported a total new contract amount of 845.07 billion yuan from January to October, a decrease of 11.8% year-on-year, while overseas contracts increased by 7.3% to 71.16 billion yuan [4] Group 4: Shapuaisi - Shapuaisi received approval for clinical trials of deoxycorticosterone ketone solution, intended for use during cataract surgery [5] Group 5: Jianfeng Group - Jianfeng Group's subsidiary received approval for clinical trials of a new drug for treating advanced non-squamous non-small cell lung cancer [7] Group 6: Chongqing Steel - Chongqing Steel announced the resignation of its president Meng Wenwang due to work adjustments [8] Group 7: Tianma Technology - Tianma Technology reported an output of approximately 1732.99 tons of eel in October, with a total output of about 15218.73 tons from January to October [10] Group 8: Qingyuan Co. - Qingyuan Co.'s controlling shareholder reduced holdings of convertible bonds by 685,400 units, accounting for 13.71% of the total issuance [11] Group 9: Spring Airlines - Spring Airlines reported a passenger turnover of 506,200.49 million kilometers in October, a year-on-year increase of 20.06% [12] Group 10: China Merchants Port - China Merchants Port reported a total container volume of 17.1714 million TEUs from January to October, a year-on-year increase of 5.1% [13] Group 11: Yangdian Technology - Yangdian Technology announced a change in control following a share transfer [15] Group 12: Wanfu Biology - Wanfu Biology decided to postpone the implementation of its Knowledge City production base project [16] Group 13: Iwu Biology - Iwu Biology terminated the research project for a specific drug, which will reduce its 2025 net profit by approximately 333.79 million yuan [17] Group 14: Hainan Rubber - Hainan Rubber received an insurance payout of 22.9241 million yuan due to revenue loss from rubber price fluctuations [19] Group 15: Xinjiang Tianye - Xinjiang Tianye plans to establish a joint venture with Tianchi Energy to develop coal chemical projects [20] Group 16: China Coal Energy - China Coal Energy's executive director and president Zhao Rongzhe resigned due to reaching retirement age [22] Group 17: Huading Co. - Huading Co. received approval for a stock issuance to specific investors from the Shanghai Stock Exchange [24] Group 18: Zhongmu Co. - Zhongmu Co. decided to waive its right of first refusal for a 4.04% stake in a subsidiary [25] Group 19: Tianlong Co. - Tianlong Co. reported that its subsidiary's stock issuance was approved by the Beijing Stock Exchange [26] Group 20: Hualan Co. - Hualan Co.'s subsidiary plans to invest 20 million yuan in a biotechnology company [27] Group 21: Haichen Pharmaceutical - Haichen Pharmaceutical received a drug registration certificate for a new injection [28] Group 22: Aier Eye Hospital - Aier Eye Hospital plans to invest 300 million yuan in wealth management products [29] Group 23: Xiamen Engineering Machinery - Xiamen Engineering Machinery announced a planned share reduction by a major shareholder [30] Group 24: Guotai Group - Guotai Group successfully acquired 100% of a mining technology company for 110.1 million yuan [31] Group 25: Wanfeng Aowei - Wanfeng Aowei reached a settlement regarding an arbitration matter with a subsidiary [32] Group 26: Taihe Technology - Taihe Technology is undergoing technical upgrades for its ethylene carbonate project [33] Group 27: Renhe Pharmaceutical - Renhe Pharmaceutical's controlling shareholder plans to reduce holdings by 0.21% [34] Group 28: Changshu Bank - Changshu Bank's second-largest shareholder increased its stake to 3.98% [35] Group 29: Overseas Chinese Town A - Overseas Chinese Town A reported a 57% decrease in contract sales in October [36] Group 30: Canadian Solar - Canadian Solar's controlling shareholder expects total revenue of 1.3 to 1.5 billion USD in Q4 2025 [38] Group 31: Zhonggong Education - Zhonggong Education's controlling shareholder's shares will be auctioned due to a loan dispute [40] Group 32: Aikexibo - Aikexibo's shareholders plan to reduce their holdings by up to 3% [42] Group 33: Wanhua Chemical - Wanhua Chemical's shareholder plans to reduce holdings by up to 0.5% [44] Group 34: Jujie Microfiber - Jujie Microfiber's controlling shareholder plans to reduce holdings by up to 2% [45] Group 35: Wangsu Technology - Wangsu Technology's shareholder plans to reduce holdings by up to 1% [46] Group 36: Tianli Lithium Energy - Tianli Lithium Energy received a patent for lithium-ion battery materials [47] Group 37: Heshun Electric - Heshun Electric won a 40 million yuan project for energy storage services [49] Group 38: Changchun High-tech - Changchun High-tech's subsidiary received FDA approval for a clinical trial of a new drug [51] Group 39: Dongrui Co. - Dongrui Co. received an additional export quota for live pigs to Hong Kong [52] Group 40: Zhongwei Co. - Zhongwei Co. set the H-share issuance price at 34 HKD per share [53] Group 41: Fospower Technology - Fospower Technology plans to invest in a lithium sulfide project with partners [54]

10 月份，本公司部分新签单笔合同额在人民币 10 亿元以上的重大工程承包合同 如下： 以上数据为阶段性数据，仅供投资者参考，最终数据以定期报告披露数据为准。 特此公告。 中国冶金科工股份有限公司董事会 2025 年 11 月 14 日 A 股简称：中国中冶 A 股代码：601618 公告编号：临 2025-053 中国冶金科工股份有限公司 2025 年 1-10 月新签合同情况简报 中国冶金科工股份有限公司（以下简称"本公司"）董事会及全体董事保证本 公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、 准确性和完整性承担法律责任。 本公司2025年1-10月新签合同额人民币8,450.7亿元，较上年同期降低 11.8%， 其中新签海外合同额人民币 711.6 亿元，较上年同期增长 7.3%。 1 单位：人民币亿元 序 号 合同签订主体 项目（合同）名称 合同 金额 1 中国十七冶集团有限公司 广州市黄埔区龙湖街埔联片区城中村改 造项目 AZ-04 地块、AZ-06 地块、AZ-08 地块施工图设计及施工总承包合同 18.4 2 中国三冶集团有限公司 香格里拉市洪鑫矿业有限责任公司雪鸡 ...